FDA Withdraws Durvalumab Indication For Bladder Cancer

Immunotherapy drug- Durvalumab's indication for the treatment of bladder cancer has been withdrawn in the US after it failed to improve survival.

from Medindia Health News https://ift.tt/2ZW91Q5